Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion | 137 |
| A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion | 90 |
Total Visits per Month
| November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
|---|---|---|---|---|---|---|---|
| A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion | 6 | 2 | 5 | 2 | 3 | 4 | 7 |
File Downloads
| Views | |
|---|---|
| hdl_102929.pdf(legacy) | 83 |
| hdl_102929.pdf | 69 |
Top Country Views
| Views | |
|---|---|
| Australia | 104 |
| United States | 62 |
| China | 12 |
| Netherlands | 8 |
| Vietnam | 8 |
| Singapore | 6 |
| France | 3 |
| Sweden | 3 |
| Germany | 2 |
| Ireland | 2 |
Top City Views
| Views | |
|---|---|
| Kaleen | 53 |
| Ashburn | 16 |
| Fairfield | 9 |
| Hanoi | 8 |
| Rotterdam | 8 |
| Cambridge | 7 |
| Singapore | 4 |
| Des Moines | 2 |
| New York | 2 |
| Adelaide CBD | 1 |